These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37012306)

  • 1. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.
    Morató X; Marquié M; Tartari JP; Lafuente A; Abdelnour C; Alegret M; Jofresa S; Buendía M; Pancho A; Aguilera N; Ibarria M; Diego S; Cuevas R; Cañada L; Calvet A; Antonio EE; Pérez-Cordón A; Sanabria Á; de Rojas I; Nuñez-Llaves R; Cano A; Orellana A; Montrreal L; Cañabate P; Rosende-Roca M; Vargas L; Bojaryn U; Ricciardi M; Ariton DM; Espinosa A; Ortega G; Muñoz N; Lleonart N; Alarcón-Martín E; Moreno M; Preckler S; Tantinya N; Ramis M; Nogales AB; Seguer S; Martín E; Pytel V; Valero S; Gurruchaga M; Tárraga L; Ruiz A; Boada M
    Sci Rep; 2023 Apr; 13(1):5406. PubMed ID: 37012306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
    CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N;
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1087-95. PubMed ID: 24633934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Ong PA; Yuda T; Ng LL; Mamun K; Merchant RA; Chen C; Dominguez J; Marasigan S; Ampil E; Nguyen VT; Yusoff S; Chan YF; Yong FM; Krairit O; Suthisisang C; Senanarong V; Ji Y; Thukral R; Ihl R
    CNS Neurosci Ther; 2019 Feb; 25(2):288-298. PubMed ID: 30648358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with
    García-Alberca JM; Gris E; Mendoza S
    Alzheimers Dement (N Y); 2022; 8(1):e12338. PubMed ID: 35929002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.
    Le Bars PL; Velasco FM; Ferguson JM; Dessain EC; Kieser M; Hoerr R
    Neuropsychobiology; 2002; 45(1):19-26. PubMed ID: 11803237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q
    Front Pharmacol; 2023; 14():1147860. PubMed ID: 37063270
    [No Abstract]   [Full Text] [Related]  

  • 12. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
    Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
    J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA; Crews WD
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract.
    Solfrizzi V; Panza F
    J Alzheimers Dis; 2015; 43(2):605-11. PubMed ID: 25352453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Isaac MG; Clark AR; Rusted J; Tabet N
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD002854. PubMed ID: 23152215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective.
    Lautenschlager NT; Ihl R; Müller WE
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S46-50. PubMed ID: 22784429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Dysfunction and Affective Mood Disorder Screening in Patients With Chronic Inflammatory Bowel Disease: Protocol for a Prospective Case-Control Study.
    Sarb OF; Vacaras V; Sarb A; Iacobescu M; Tantau AI
    JMIR Res Protoc; 2023 Oct; 12():e50546. PubMed ID: 37824197
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.